Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis. 1998

H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
Department of Neurology, University of Göttingen, Germany. htumani@med.uni-goettingen.de

Although meninges represent a major site of biosynthesis, beta-trace protein (beta-trace) has not been studied in the cerebrospinal fluid (CSF) of meningitis patients. We measured beta-trace in lumbar CSF of normal controls (n = 27) and in patients with various neurological diseases (n = 92) by an immunonephelometric assay. The mean concentration of beta-trace in CSF of control patients was 16.6+/-3.6 mg/l. In bacterial meningitis (n = 41), CSF beta-trace was significantly decreased (8.7+/-3.9 mg/l; P< 0.001), whereas in spinal canal stenosis it was elevated (29.2+/-10.3 mg/l; P= 0.002). In viral meningoencephalitis (n = 12), beta-trace CSF concentrations were normal. Beta-trace concentrations remained below the normal range even after curing of bacterial meningitis, and normalisation of CSF leucocytes and blood-CSF barrier function. Beta-trace may be a useful tool for studying the pathophysiology of bacterial meningitis.

UI MeSH Term Description Entries
D008297 Male Males
D008587 Meningitis, Viral Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Viral Meningitis,Meningitides, Viral,Viral Meningitides
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
January 1981, Scandinavian journal of infectious diseases,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
January 2013, Przeglad epidemiologiczny,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
January 2016, Przeglad epidemiologiczny,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
December 1987, The Medical journal of Malaysia,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
June 1999, Presse medicale (Paris, France : 1983),
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
January 2014, Przeglad epidemiologiczny,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
January 1981, The Journal of pediatrics,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
March 1979, Journal of clinical microbiology,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
January 1979, The Journal of international medical research,
H Tumani, and H Reiber, and R Nau, and H W Prange, and K Kauffmann, and M Mäder, and K Felgenhauer
April 1982, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!